Replies to post #11980 on Algernon Pharmaceuticals Inc (AGNPF)

[McMagyar]

Smoki.. but this is the trial that should be 100% enrolled with 4 th quarter reporting..

How could they make this review now and then change it regarding phase 3?..

Seems like this is the green light for phase 3 now we just need tonfigure our how many for Stat Sig based upon efficacy data over placebo cohort..